State WA
Clinical Trials in Washington
Recruiting clinical trials with at least one study location in Washington. Data updated daily from ClinicalTrials.gov.
Top Conditions in Washington
Colorectal Cancer (8)Breast Cancer (7)Prostate Cancer (7)Malignant Solid Neoplasm (6)Acute Myeloid Leukemia (5)Melanoma (5)Non-small Cell Lung Cancer (5)Acute Lymphoblastic Leukemia (4)Ovarian Cancer (4)Hematopoietic and Lymphatic System Neoplasm (4)Mantle Cell Lymphoma (3)Mixed Phenotype Acute Leukemia (3)
NCT06456905 N/A
Recruiting
Automated Reinforcement Management Systems, Phase II
Condition
Alcohol Use Disorder
Enrollment
125 pts
Location
United States
Sponsor
Washington State University
NCT07408141 N/A
Recruiting
MiniMed Fit Payload Wear Study
Condition
Diabetes (Insulin-requiring, Type 1 or Type 2)
Enrollment
175 pts
Location
United States
Sponsor
Medtronic Diabetes
NCT07219966 Phase 3
Recruiting
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disor...
Condition
Alcohol Use Disorder
Enrollment
1,100 pts
Location
United States, Belgium, China
Sponsor
Eli Lilly and Company
NCT07197866 Phase 2
Recruiting
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple Syste...
Condition
Multiple System Atrophy
Enrollment
200 pts
Location
United States, Germany, Israel
Sponsor
Teva Branded Pharmaceutical Pr
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT07225686 Phase 3
Recruiting
Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sl...
Condition
Obesity
Enrollment
250 pts
Location
United States, Australia, Canada
Sponsor
Amgen
NCT06991556 Phase 2
Recruiting
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone ...
Condition
Metastatic Hormone-sensitive Prostate Cancer
Enrollment
150 pts
Location
United States, Australia, Canada
Sponsor
Novartis Pharmaceuticals
NCT06411431 N/A
Recruiting
Early Chest Tube Removal After Surgery for Primary Spontaneous Pneumothorax: A R...
Condition
Primary Spontaneous Pneumothorax
Enrollment
200 pts
Location
United States
Sponsor
Swedish Medical Center
NCT03016819 Phase 3
Recruiting
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarco...
Condition
Alveolar Soft Part Sarcoma
Enrollment
325 pts
Location
United States, China, Italy
Sponsor
Advenchen Laboratories, LLC
NCT07037901 Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants Wit...
Condition
Atopic Dermatitis
Enrollment
220 pts
Location
United States, Canada
Sponsor
Inmagene LLC
NCT07225946 Phase 3
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metas...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
800 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06928662 Phase 1, Phase 2
Recruiting
Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiatio...
Condition
Acute Myeloid Leukemia
Enrollment
36 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT06047379 Phase 1, Phase 2
Recruiting
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblast...
Condition
Diffuse Astrocytoma, IDH-Mutant
Enrollment
134 pts
Location
United States
Sponsor
Neonc Technologies, Inc.
NCT06711588 N/A
Recruiting
Automatic Prosthetic Foot Stiffness Modulation to Improve Balance
Condition
Lower Limb Amputation Below Knee
Enrollment
20 pts
Location
United States
Sponsor
Seattle Institute for Biomedic
NCT06568237 Phase 2
Recruiting
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Mul...
Condition
Multiple System Atrophy
Enrollment
350 pts
Location
United States, France, Germany
Sponsor
Teva Branded Pharmaceutical Pr
NCT06679140 Phase 3
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolesc...
Condition
COVID-19 SARS-CoV-2 Infection
Enrollment
2,330 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer
NCT06384261 Phase 2
Recruiting
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and ...
Condition
Leukemia, Myeloid, Acute
Enrollment
120 pts
Location
United States, Canada, Germany
Sponsor
OncoVerity, Inc.
NCT04703842 Phase 1, Phase 2
Recruiting
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure Wit...
Condition
Congestive Heart Failure
Enrollment
57 pts
Location
United States
Sponsor
Sardocor Corp.
NCT04462770 Phase 3
Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrom...
Condition
Dravet Syndrome
Enrollment
150 pts
Location
United States, Canada, Georgia
Sponsor
Epygenix
NCT06840483 Phase 2
Recruiting
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
Condition
Breast Cancer
Enrollment
66 pts
Location
United States, Australia, Belgium
Sponsor
BicycleTx Limited
NCT05465629 N/A
Recruiting
Viome Nutritional Programs to Improve Clinical Outcomes for Gastrointestinal Con...
Condition
Gastrointestinal Health
Enrollment
150 pts
Location
United States
Sponsor
Viome
NCT05894239 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Ph...
Condition
Metastatic Breast Cancer
Enrollment
230 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT07364773 N/A
Recruiting
Enhancing Rehabilitation Participation in Patients With SCI/D Using Motivational...
Condition
Spinal Cord Injuries (SCI)
Enrollment
180 pts
Location
United States
Sponsor
Shirley Ryan AbilityLab